OneAscent Financial Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-512
Closed -$278K 217
2024
Q2
$278K Sell
512
-160
-24% -$84.6K 0.04% 198
2024
Q1
$348K Sell
672
-259
-28% -$129K 0.04% 262
2023
Q4
$439K Buy
931
+76
+9% +$35.1K 0.05% 208
2023
Q3
$372K Buy
+855
New +$388K 0.1% 153
2023
Q2
Sell
-838
Closed -$385K 149
2023
Q1
$385K Sell
838
-119
-12% -$56.6K 0.16% 84
2022
Q4
$491K Buy
957
+117
+14% +$59.4K 0.21% 54
2022
Q3
$381K Sell
840
-208
-20% -$99.5K 0.15% 95
2022
Q2
$506K Buy
1,048
+275
+36% +$136K 0.23% 74
2022
Q1
$379K Sell
773
-31
-4% -$14.2K 0.27% 61
2021
Q4
$373K Buy
+804
New +$338K 0.71% 49
2021
Q1
$519K Buy
+1,446
New +$465K 0.51% 31

Other funds holding ELV

OneAscent Financial Services's ELV Position: Q3 2024 in Review

OneAscent Financial Services sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 512 shares — an estimated $278K sold.

OneAscent Financial Services first reported a position in ELV in Q1 2021 and held it in 11 quarters. The position peaked at $519K in Q1 2021. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • OneAscent Financial Services reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • OneAscent Financial Services sold 512 Elevance Health shares in Q3 2024, an estimated $278K.
  • OneAscent Financial Services first reported a position in Elevance Health in Q1 2021 and held it in 11 quarters.
  • OneAscent Financial Services's Elevance Health position peaked at $519K in Q1 2021.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on OneAscent Financial Services's 13F filing for Q3 2024, filed 7 Nov 2024.